An FDA advisory panel spent two days in late July reviewing the most popular injectable peptides, and by the end it voted 8 to 6 that four of them can be safely produced by compounding pharmacies. That reverses Biden-era restrictions that had kept these substances in a regulatory grey zone. For the longevity industry, this is the starting gun. Every med spa, recovery lounge, and wellness-forward studio now has a clear path to a peptide menu, and a lot of them are going to sprint for it.
Here is why you should slow down before you do. Peptides (short chains of amino acids marketed for recovery, muscle, and anti-aging effects) are about to go from something operators quietly sourced offshore to something they can advertise on the wall. The proponents' own argument for the change, reported by NPR and CBS News, was that prohibition had fueled a grey market of unvetted overseas suppliers. The vote does not make peptides proven. It makes them legal to compound. Those are different things, and members will not know the difference. You will have to.
| Before the vote | After the vote | |
|---|---|---|
| Supply channel | Overseas grey market | Regulated compounding pharmacy |
| Operator posture | Quiet, deniable | Public, promotable |
| Member's question | Where did this come from? | Should I trust you to sell it? |
Should studios add a peptide program?
Only if they can answer for it. The regulatory green light removes the sourcing excuse, not the responsibility. A wellness operator selling injectables is making an implicit health claim, and the member is buying the operator's judgment as much as the vial. If you cannot staff qualified oversight, explain the evidence honestly, and turn away the member for whom it is a bad idea, you are not offering a service. You are offering liability with a markup. The safe answer for most studios is a referral relationship, not an in-house counter.
Access just got commoditized. Judgment did not. The operators who win the longevity layer are the ones a member believes when they say this one is not for you.
— The Run RateThis is the same pattern we traced with Oura and Eli Lilly. When the product itself becomes easy to get, the defensible layer moves to interpretation, to the trusted human who tells you what to do with it. Peptides are about to prove it in the most literal way. When everyone can sell the injection, the only differentiator left is whether members believe your reason for selling it, or for not.
We have argued that the longevity coach is becoming the new personal trainer and that longevity clinics are already coming for your members. This vote accelerates both. The clinics will move first and hardest, because peptides fit their model and their liability coverage. Boutique studios that chase them on product will lose, because a studio cannot out-clinic a clinic. What a studio can own is the relationship of trust that makes a member ask you first. Protect that, and you can refer the peptide out and keep the member. Sell the peptide badly, and you lose both. The market for peptides just opened. The market for trust was always the one worth winning.